Chemomab Therapeutics Ltd.
CMMB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001534248
In the last 90 days, Chemomab Therapeutics Ltd. insiders filed 0 open-market purchases and 1 sale; 13 institutions reported holding it in 13F filings for Q2 2026, worth $615.3K in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Chemomab Therapeutics Ltd. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 15 | 13 | −2 |
| Shares | 3.31M | 3.29M | −19.3K (−0.6%) |
| Value | $15.9M | $12.2M | −$3.71M (−23.4%) |
New holders (2)
Institutions that held Chemomab Therapeutics Ltd. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Morgan Stanley | 5,595 | $21.0K | 0.00% |
| Urban Wealth Management, LLC | 2,762 | $10.0K | 0.03% |
Sold out (4)
Institutions that held Chemomab Therapeutics Ltd. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Renaissance Technologies LLC | 27,960 | $134.0K |
| JPMorgan Chase & Co | 753 | $4.00K |
| UBS Group AG | 885 | $4.00K |
| ARK Investment Management LLCSuperinvestorARK Invest | 792 | $4.00K |